Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment
- PMID: 23008124
- PMCID: PMC3632258
- DOI: 10.1007/s10461-012-0319-6
Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment
Abstract
Many HIV-infected injection drug users (IDUs) continue to use illicit substances despite being in substance use treatment. Substance use is associated with non-adherence to HIV medications; however underlying mechanisms regarding this relation are understudied. The current investigation examined the role of substance use coping in terms of the relation between substance use and HIV medication adherence. Participants were 121 HIV-infected IDUs (41 % female, M age = 47, SD = 7.1) in opioid dependence treatment. Participants completed self-report questionnaires, were administered clinical interviews and oral toxicology screens, and used a medication-event-monitoring-system cap to assess 2 week HIV medication adherence. The use of cocaine and multiple substances were significantly related to decreased medication adherence. Substance use coping mediated these associations. Findings highlight the importance of assessing, monitoring, and targeting ongoing substance use, and ways to increase positive coping for HIV-infected IDUs in substance use treatment to aid in HIV medication adherence.
Similar articles
-
Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).Addict Behav. 2018 Oct;85:88-93. doi: 10.1016/j.addbeh.2018.05.031. Epub 2018 May 31. Addict Behav. 2018. PMID: 29879611 Free PMC article.
-
The role of substance use in adherence to HIV medication and medical appointments.J Assoc Nurses AIDS Care. 2014 May-Jun;25(3):262-8. doi: 10.1016/j.jana.2013.11.001. Epub 2014 Feb 4. J Assoc Nurses AIDS Care. 2014. PMID: 24503499 Free PMC article. No abstract available.
-
Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.HIV Med. 2008 Aug;9(7):503-7. doi: 10.1111/j.1468-1293.2008.00582.x. Epub 2008 May 15. HIV Med. 2008. PMID: 18484977
-
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).Int J Drug Policy. 2007 Aug;18(4):262-70. doi: 10.1016/j.drugpo.2006.12.014. Epub 2007 Jan 26. Int J Drug Policy. 2007. PMID: 17689374 Review.
-
Mitigating the risk of HIV infection with opioid substitution treatment.Bull World Health Organ. 2013 Feb 1;91(2):148-9. doi: 10.2471/BLT.12.109553. Bull World Health Organ. 2013. PMID: 23554530 Free PMC article. Review. No abstract available.
Cited by
-
One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States.Clin Infect Dis. 2019 Feb 15;68(5):795-802. doi: 10.1093/cid/ciy556. Clin Infect Dis. 2019. PMID: 30169624 Free PMC article.
-
The next therapeutic challenge in HIV: polypharmacy.Drugs Aging. 2013 Aug;30(8):613-28. doi: 10.1007/s40266-013-0093-9. Drugs Aging. 2013. PMID: 23740523 Free PMC article. Review.
-
Childhood Sexual Abuse and Syringe Sharing Among People Who Inject Drugs.AIDS Behav. 2015 Aug;19(8):1415-22. doi: 10.1007/s10461-014-0930-9. AIDS Behav. 2015. PMID: 25428283 Free PMC article.
-
Food insecurity and substance use in people with HIV infection and substance use disorder.Subst Abus. 2022;43(1):104-112. doi: 10.1080/08897077.2020.1748164. Epub 2020 May 6. Subst Abus. 2022. PMID: 32374225 Free PMC article.
-
Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.Sex Transm Infect. 2014 Aug;90(5):418-22. doi: 10.1136/sextrans-2013-051408. Epub 2014 Feb 12. Sex Transm Infect. 2014. PMID: 24523347 Free PMC article.
References
-
- de Olalla PG, Knobel H, Carmona A, Guelar A, Lopez-Colomes JL, Cayla JA. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J Acquir Immune Defic Syndr. 2002;30:105–10. - PubMed
-
- Low-Beer S, Yip B, O’Shaughnessy MV, et al. Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000;23:360–1. - PubMed
-
- Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30. - PubMed
-
- Thompson MA, Aberg JA, Cahn P, et al. Antiretroviral treatment of adult HIV infection. J Am Med Assoc. 2010;304:321–33. - PubMed
-
- Kuritzkes DR. HIV drug resistance: new insight and updated practices. Physicians’ Res Netw. 2004;9:9–13.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous